Endobronchial Ultrasound and Lymphoproliferative Disorders: A Retrospective Study Seher Iqbal, MD, Zachary S. DePew, MD, Paul J. Kurtin, MD, Anne-Marie G. Sykes, MD, Geoffrey B. Johnson, MD, Eric S. Edell, MD, Thomas M. Habermann, MD, Fabien Maldonado, MD The Annals of Thoracic Surgery Volume 94, Issue 6, Pages 1830-1834 (December 2012) DOI: 10.1016/j.athoracsur.2012.08.051 Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Diagram illustrates the procedure by which diagnosis was made, the number of recurrent cases, and final diagnosis. (BCL = B-cell lymphoma; EBUS-TBNA = endobronchial ultrasound-guided transbronchial needle aspiration; HL = Hodgkin lymphoma; LPD = lymphoproliferative disease; MALT = mucosa associated lymphoid tissue lymphoma; PTLD = posttransplant lymphoproliferative disorder; SLL/CLL = small lymphocytic lymphoma/chronic lymphocytic leukemia; TCL = T-cell lymphoma.) The Annals of Thoracic Surgery 2012 94, 1830-1834DOI: (10.1016/j.athoracsur.2012.08.051) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Diagram illustrates the method by which diagnosis was made for new vs recurrent cases. (Dx = diagnosis; EBUS-TBNA = endobronchial ultrasound-guided transbronchial needle aspiration; LPD = lymphoproliferative disease; Med = mediastinoscopy.) The Annals of Thoracic Surgery 2012 94, 1830-1834DOI: (10.1016/j.athoracsur.2012.08.051) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions